Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

TNYA Tenaya Therapeutics Inc

4,18

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:00:00

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Tenaya Therapeutics Charts.

Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Tenaya Therapeutics Charts.

News Tenaya Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Dienstag 14 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
Donnerstag 2 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Montag 18 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
Montag 18 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 28 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
Dienstag 27 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications
Montag 26 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 17 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Samstag 17 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Donnerstag 8 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Tenaya Therapeutics Inc News-Artikel

Deutsche Telekom

JP Morgan Chase

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen